Loading ...
Sorry, an error occurred while loading the content.

Fwd: NATAP: 26 recent Hep C Articles on website

Expand Messages
  • claudine intexas
    nataphcv@natap.org wrote:Date: Fri, 7 Oct 2005 08:50:56 EDT To: nataphcv@natap.org, nataphcvhiv@natap.org, natapdoctors@natap.org, natapindustry@natap.org CC:
    Message 1 of 1 , Oct 9, 2005
    • 0 Attachment
      nataphcv@... wrote:Date: Fri, 7 Oct 2005 08:50:56 EDT
      To: nataphcv@..., nataphcvhiv@...,
      natapdoctors@..., natapindustry@...
      CC:
      From: nataphcv@...
      Subject: NATAP: 26 recent Hep C Articles on website

      NATAP http://natap.org/
      _______________________________________________
      26 RECENT HEPATITIS C ARTICLES ON NATAP WEBSITE
      http://www.natap.org

      Toll-Like Receptors: new therapy to stimulate immune system - (10/06/05)

      Increased Rates of Liver Cell Death in HCV/HIV Coinfection - (10/05/05)

      Biomarkers used to predict recurrent disease in hepatitis C transplant patients - (10/05/05)

      24 Week PegIntron/RBV Therapy Approved in Europe for HCV Genotype 1 & Low Viral Load - (10/05/05)

      Presence of Hepatitis C Virus (HCV) RNA in the Genital Tracts of HCV/HIV-1-Coinfected Women - (10/05/05)

      Undetectable HIV May Slow Fibrosis in HCV/HIV Coinfected Patients - (10/04/05)

      New HCV Antisense Drug - (10/04/05)

      Hepatitis C Vaccine Candidate - (10/04/05)

      Two New HCV Polymerase Inhibitors: early study data show potency & perhaps once daily dosing - (10/04/05)

      New HCV Drug NM283 HBV Drug LdT at AASLD - (10/03/05)

      New HCV Protease Inhibitor VX-950 - (10/03/05)

      Hepatitis C and liver transplantation - (10/03/05)

      Breakthrough for HCV research: in vitro HCV replication - (10/03/05)

      Asians 'risk fatal liver disease' - (10/03/05)

      New HCV & HBV Drugs: XTL-6865, XTL2125 - (09/30/05)

      Britain 'failing' on hepatitis C - (09/30/05)

      Hepatitis C: Current approaches in pediatrics - (09/30/05)

      Noninvasive Fibrosis Test Performs Well - (09/30/05)

      New Toll-like Receptor Drug Actilon for HCV Therapy - (09/29/05)

      Psych Impairment in Coinfected Women - (09/29/05)

      Flamel Technologies Announces Positive Preliminary Results of a Phase I/II Trial of IFN-alpha-XL in Patients with Chronic Hepatitis C Virus Infection - (09/29/05)

      Chronic Hepatitis C in Latinos: Natural History, Treatment Eligibility, Acceptance, and Outcomes - (09/29/05)

      MIGENIX Completes First Clinical Study of Celgosivir in Chronic Hepatitis C Patients - (09/29/05)

      Bioenvision's Phase II Trial of Virostat Very Active in Hepatitis C - (09/29/05)

      New Hep C Protease Inhibitor - (09/21/05)

      Liver Injury and Changes in Hepatitis C Virus (HCV) RNA Load Associated with Protease Inhibitor-Based Antiretroviral Therapy for Treatment-Naive HCV-HIV-Coinfected Patients: Lopinavir-Ritonavir versus Nelfinavir - (09/21/05)
      _______________________________________________
      NATAP nataphcv mailing list -- nataphcv@...

      This is an annoucement-only mailing list. Do not reply.

      To unsubscribe: send a blank email to nataphcv-request@... with a subject of unsubscribe.


      For more information, see http://seven.pairlist.net/mailman/listinfo/nataphcv

      _______________________________________________


      ----------

      _______________________________________________
      NATAP nataphcv mailing list -- nataphcv@...

      This is an annoucement-only mailing list. Do not reply.

      To unsubscribe: send a blank email to nataphcv-request@... with a subject of unsubscribe.


      For more information, see http://seven.pairlist.net/mailman/listinfo/nataphcv

      _______________________________________________


      [Non-text portions of this message have been removed]
    Your message has been successfully submitted and would be delivered to recipients shortly.